Delivery Order SPE2DB20D3111-SPE2DB23FA9PY

Award Date 8/18/23
Potential Completion Date 8/21/23
Potential Value $652
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $473,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of Department of Defense health programs. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania over a one day period from July 24-25,...
The Defense Logistics Agency awarded a $213,780 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from June 29, 2023 to June 30, 2023. No...
The Defense Logistics Agency awarded a $2,067 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility to support Defense Logistics Agency programs. No major subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract vehicle and will be completed by August 28,...
The Defense Logistics Agency awarded a $887 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 27-28, 2023. No subcontractors or set aside...
The Defense Logistics Agency awarded a $1,857 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. The contract has a period of performance from June 20, 2023 through June 21, 2023 and will be performed in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order supports the DLA's mission to provide critical medicines and treatments to military personnel...
The Defense Logistics Agency awarded a $848 delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension. The firm fixed price order is valued at eight hundred forty-eight dollars and thirty-seven cents to supply the otic suspension medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period concluding on July 17, 2023. The Defense Logistics Agency routinely utilizes indefinite-delivery contracts...
The Defense Logistics Agency awarded a $2,344.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. The contract has a period of performance from September 7-8, 2023 and will be performed in Conshohocken, Pennsylvania. As the DLA supports procurement for the Department of Defense, this delivery order is likely providing an antibiotic/corticosteroid ear drop medication for treatment of outer ear infections to military...
The Defense Logistics Agency awarded a $7,262 delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension. The firm fixed price order is for 7.5mL of the otic suspension medication to support DLA programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period from July 3rd through July 5th, 2023. No set aside designation or subcontractors were identified. The order was issued under an existing...
The Defense Logistics Agency awarded a $2,969.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. The single award was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period concluding on July 3, 2023. No set aside...
The Defense Logistics Agency awarded a $512 delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension. The firm fixed price order is valued at five hundred twelve dollars and ninety-four cents to supply the ear suspension medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 5th through September 6th, 2023. No set aside designation or subcontractors were identified. The...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB23FA9PY
    Delivery Order

The Defense Logistics Agency awarded a $651.71 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of Department of Defense health programs. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania over a three-day period concluding on August 21, 2023. No subcontractors or set-aside designations were identified. The order supports DLA's mission to provide medical supplies and equipment to military treatment facilities worldwide.

Generated 12/20/23, 4:17 AM